| cpd00182 | 1972631-93-8 | amyloid-beta C-terminal motif | VGGVVIAT | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI |
cpd00183 | 1972631-92-7 | amyloid-beta C-terminal motif | GVVIAT | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00184 | 1972631-91-6 | amyloid-beta C-terminal motif | VIAT | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00185 | 1972631-90-5 | amyloid-beta C-terminal motif | LMVGGVV | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00186 | 1972631-89-2 | amyloid-beta C-terminal motif | VGGVV | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00187 | 1972631-88-1 | amyloid-beta C-terminal motif | XGVV | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00188 | 1972631-86-9 | amyloid-beta C-terminal motif | LMVGGVVIA | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00189 | 1972631-85-8 | amyloid-beta C-terminal motif | VGGVVIA | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00190 | 1972631-84-7 | amyloid-beta C-terminal motif | GVVIA | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00191 | 1972631-83-6 | amyloid-beta C-terminal motif | XVIA | Trolox | Alzheimer’s disease therapy, anti-aggregation and antioxidant | amide | Arai, Takuya;et.al (2016)
DOI | cpd00192 | 1922111-45-2 | cell-penetrating peptide BP16 | GFLGKKLFKKILKKLK | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00193 | 1922111-44-1 | cell-penetrating peptide BP17 | XKKKLFKKILKKL | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00194 | 1922111-43-0 | cell-penetrating peptide BP18 | KKLFKKILKKLK | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00195 | 1922111-42-9 | cell-penetrating peptide BP19 | GFLGKKLFKKILKKL | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00196 | 1922111-41-8 | cell-penetrating peptide BP20 | XKKKLFKKILKKL | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00197 | 1922111-40-7 | cell-penetrating peptide BP21 | XKKKLFKKILKKL | 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00198 | 1922111-39-4 | cell-penetrating peptide BP22 | KKLFKKILKKLK | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00199 | 1922111-38-3 | cell-penetrating peptide BP23 | KKLFKKILKKL | (2S,2S′)-1,1′-bis(pyrid-2-ylmethyl)-2,2′-bipyrrolidine ((S,S′)-BPBP) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00200 | 1922111-37-2 | cell-penetrating peptide BP24 | KKLFKKILKKLK | 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00201 | 1922111-36-1 | cell-penetrating peptide BP25 | KKLFKKILKKL | 1,4-dimethyl-7-(2-pyridylmethyl)-1,4,7-triazacyclononane (Me2PyTACN) | Anticancer therapy, pro-oxidant | amide | Soler, M.et.al (2016)
DOI | cpd00202 | 942941-28-8 | | GXXXXXXXXXXXXX | Fluorescein | Antimicrobial therapy, antibacterial (Mycobacterium and Salmonela) | amide | Brezden, Anna;et.al (2016)
DOI | cpd00203 | 1994357-15-1 | | GXXXXXXXXXXXXX | Kanamycin A | Antimicrobial therapy, antibacterial (Mycobacterium and Salmonela) | amide | Brezden, Anna;et.al (2016)
DOI | cpd00204 | 1975225-67-2 | T2635-truncated peptide (HIV-1 fusion inhibitor) | XEYAARIEALIRAAQEQQKK | N-carboxyphenylpyrrole compound Gls-22 | Antimicrobial, antiviral (HIV-1) | amide | Liang, Guodong;et.al (2016)
DOI | cpd00205 | 1975225-66-1 | T2635-truncated peptide (HIV-1 fusion inhibitor) | XEYAARIEALIRAAQEQQKK | Indole compound 6j | Antimicrobial, antiviral (HIV-1) | amide | Liang, Guodong;et.al (2016)
DOI | cpd00206 | 1975225-65-0 | T2635-truncated peptide (HIV-1 fusion inhibitor) | XEYAARIEALIRAAQEQQKKNEE | N-carboxyphenylpyrrole compound Gls-22 | Antimicrobial, antiviral (HIV-1) | amide | Liang, Guodong;et.al (2016)
DOI | cpd00207 | 1975225-64-9 | T2635-truncated peptide (HIV-1 fusion inhibitor) | XEYAARIEALIRAAQEQQKKNEE | Indole compound 6j | Antimicrobial, antiviral (HIV-1) | amide | Liang, Guodong;et.al (2016)
DOI | cpd00208 | 1975225-63-8 | T2635-truncated peptide (HIV-1 fusion inhibitor) | XEYAARIEALIRAAQEQQEKNEAALRE | N-carboxyphenylpyrrole compound Gls-22 | Antimicrobial, antiviral (HIV-1) | amide | Liang, Guodong;et.al (2016)
DOI | cpd00209 | 1988771-85-2 | cell division cycle 6 (CDC6) | SKLGRFTFCSC | Purvalanol B (PVB) | Anticancer therapy, kinase inhibition (CDK2) | amide | Wang, Wei;et.al (2016)
DOI | cpd00210 | 1210041-06-7 | α-helical peptide | GNNRPVYIPQPRPPHPRL | 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin | Synthesis, self-assembling chiral supramolecular structures | amide | Biscaglia, Francesca;et.al (2016)
DOI | cpd00211 | 1541183-49-6 | | GTRSSRAGLQFPVGRVHRLLRK | 5-(4-carboxyphenyl)-10,15,20-triphenylporphyrin | Synthesis, self-assembling chiral supramolecular structures | amide | Biscaglia, Francesca;et.al (2016)
DOI | 
